Cargando…

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test

BACKGROUND: The Asia-Pacific Colorectal Screening (APCS) score is effective to screen high-risk groups of advanced colorectal neoplasia (ACN) patients but needs revising and can be combined with the fecal immunochemical test (FIT). This paper aimed to improve the APCS score and evaluate its use with...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xu-xia, Yuan, Si-yi, Li, Wen-bin, Yang, Hong, Ji, Wen, Wang, Zhi-qiang, Hao, Jian-yu, Chen, Chuan, Chen, Wei-qing, Gao, Ying-xin, Li, Ling-bo, Cheng, Kai-liang, Qian, Jia-ming, Wang, Li, Li, Jing-nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935212/ https://www.ncbi.nlm.nih.gov/pubmed/31881948 http://dx.doi.org/10.1186/s12876-019-1146-2

Ejemplares similares

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening
por: Ze, Yuan, et al.
Publicado: (2023)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Risk Scoring Systems for Predicting the Presence of Colorectal Neoplasia by Fecal Immunochemical Test Results in Chinese Population
por: Wu, Weimiao, et al.
Publicado: (2022)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

An adjusted Asia-Pacific colorectal screening score system to predict advanced colorectal neoplasia in asymptomatic Chinese patients
por: Zhang, Chenchen, et al.
Publicado: (2023)

Quality Improvement of Sample Collection Increases the Diagnostic Accuracy of Quantitative Fecal Immunochemical Test in Colorectal Cancer Screening: A Pilot Study
por: Zhou, Ru-chen, et al.
Publicado: (2021)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening
por: Burns, Shohei, et al.
Publicado: (2023)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy
por: Liao, Yi, et al.
Publicado: (2018)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening
por: Cai, Shan-Rong, et al.
Publicado: (2016)

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
por: Chiu, Han-Mo, et al.
Publicado: (2015)

Mitigating the impact of COVID-19 on colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region
por: Chiu, Han-Mo, et al.
Publicado: (2021)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study
por: Wu, Dong, et al.
Publicado: (2014)

Feasibility of quantification based on novel evaluation with stool DNA and fecal immunochemical test for colorectal cancer detection
por: Xu, Hongli, et al.
Publicado: (2022)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
por: Malagón, Marta, et al.
Publicado: (2020)

Clinical evaluation of a multitarget fecal immunochemical test‐sDNA test for colorectal cancer screening in a high‐risk population: a prospective, multicenter clinical study
por: Hu, Ye‐Ting, et al.
Publicado: (2023)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022)

The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort
por: Luu, Xuan Quy, et al.
Publicado: (2021)

Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
por: Kong, Yunxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tej737qca0n42mc8p3hr95p0nc